Advances in radiotherapy for pancreatic cancer from 2019 to 2020
DOI:10.3969/j.issn.1001-5256.2021.03.048
- VernacularTitle:2019年—2020年胰腺癌放射治疗新进展
- Author:
Gang REN
1
;
Yingjie WANG
Author Information
1. Department of Radiotherapy, Air Force Medical Center, Beijing 100142, China
- Publication Type:Research Article
- Keywords:
Pancreatic Neoplasms;
Radiotherapy;
Combined Modality Therapy
- From:
Journal of Clinical Hepatology
2021;37(3):733-736
- CountryChina
- Language:Chinese
-
Abstract:
With the rapid development of radiotherapy equipment, imaging technology, and artificial intelligence, radiotherapy has entered the era of precision therapy. Radiotherapy is one of the important methods for the treatment of pancreatic cancer, and rapid progress has been made in related concepts and technical models of radiotherapy in recent years. With reference to the latest advances in radiotherapy technology and the change of radiotherapy dose mode, which the experts in the field of radiotherapy are concerned with, this article reviews and analyzes recent articles and points out that multimodal images play an important role in guiding radiotherapy for pancreatic cancer, and the dose mode of radiotherapy develops to high-dose hypofractionated radiotherapy. The effect of neoadjuvant radiotherapy has been further confirmed, and strong chemotherapy with the combination of multiple drugs is the main radiotherapy regimen for pancreatic cancer.
